Skip to content
BioSpace· Michael Gibney·· 4 hours agoPickScore77

Veradermics’ minoxidil pill improves hair coverage in men in Phase 3

In brief

Veradermics' oral extended-release minoxidil, VDPHL01, improved hair coverage in men with mild-to-moderate androgenetic alopecia in the Phase 3 Study 304, which enrolled more than 500 patients dosed once or twice daily.

Why it matters

Study 304 provides specific figures on hair-density gains and patient-reported improvement rates against a standard of care with no new approval in nearly 30 years.

Source: BioSpace

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org